Patients with advanced cancer were twice as likely to report receiving life-extending care despite an expressed preference for comfort-focused care. Discordant care did not improve 24-month survival ...
As colorectal cancer rates rise among young people, most patients with advanced disease still only have one treatment option: ...
The FDA has accepted a new drug application (NDA) for zipalertinib for the treatment of patients with locally advanced or ...
Read full article: Virginia Tech sophomore starts foundation to assist Carilion Clinic’s new Cancer Center But first they all pitched in to build handicapped access ramps. 51 minutes ago Renovation ...
Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...
Revolution Medicines reported positive results from a Phase 3 trial of its experimental drug daraxonrasib in patients with ...
Please provide your email address to receive an email when new articles are posted on . Many patients with advanced cancer receive treatments focused on longevity, even if they prioritize comfort.
The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to ...
NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, ...
PRISM coaching improved hope, resilience, and quality of life in AYAs with advanced cancer, with lasting benefits on anxiety and care engagement. The program includes four individual sessions and a ...
Herpes has been called “the gift that keeps on giving” — finally, its presence has come in handy. Roughly two-thirds of the global population has been infected with herpes simplex virus type 1 (HSV-1) ...
It is known that high blood sugar, high blood pressure, chronic kidney disease, and obesity, increase the risk of certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results